drugset / Trial / NCT04238793
Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
RandomizedParallel-groupTriple-blindTreatment
Summary
Escalating single-dose design study to determine the safety, tolerability, and analgesic activity of KLS-2031
Timeline
- Start
- 2020-04-16
- Primary completion
- 2023-10-18
- Completion
- 2023-10-18
Outcome
Met primary endpoint
release “요천추 신경근병증(LSR) 환자 대상 미국 임상 1/2a상에서 일차 목적인 약물의 안전성과 내약성을 입증했다.” kolonls.co.kr ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KLS-2031 | Unknown | 1e+11 vg | Other |
| Subject | KLS-2031 | Unknown | 1e+12 vg | Other |
| Subject | KLS-2031 | Unknown | 1e+13 vg | Other |